Gilteritinib, sold under the brand name Xospata, is an anti-cancer drug.
Gilteritinib, sold under the brand name Xospata, is an anti-cancer drug.
==Mechanism of action== Gilteritinib acts as an inhibitor of FLT3, hence it is a tyrosine kinase inhibitor.
Discovered by embedding cosine similarity (sentence-transformers MiniLM, 384-dim).